Cardiac tumors diagnostic study of choice

Jump to navigation Jump to search

Cardiac tumors Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Tumors from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac tumors diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac tumors diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac tumors diagnostic study of choice

CDC on Cardiac tumors diagnostic study of choice

Cardiac tumors diagnostic study of choice in the news

Blogs on Cardiac tumors diagnostic study of choice

Directions to Hospitals Treating Cardiac tumors

Risk calculators and risk factors for Cardiac tumors diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Dheeraj Makkar, M.D.[2]

Overview

Diagnostic Study of Choice

Multiple cardiovascular imaging modalities could be used to outline the structure of heart mass and its potential implications on the function.

  • The primary objective of cardiovascular imaging is to define the location, extent, and vascularity of the tumor and to determine any hemodynamic effects, tumor and evaluate for invasion into myopericardium.
  • All patients should undergo transthoracic echocardiography (TTE) in 2D.
  • Contrast echocardiography permits the evaluation of tumor vasculature and hence facilitates the distinction between vascular malignancies and avascular tumors or thrombus.[1]
  • Transesophageal echocardiography is particularly beneficial for visualizing atria-based malignancies when the exact location of attachment cannot be determined using transthoracic echocardiography (TTE) and evaluating their connection to the venae cavae.[2]
  • Cardiac MRI sequencing can be utilized to determine the tumor's fat, water, vasculature, and ferrous content.

In secondary cardiac tumors, Computed tomography (CT) may be useful for screening prospective primary tumor locations in the chest, abdomen, and pelvis.[3]

Biopsy gives the ultimate diagnosis. Percutaneous cardiac biopsy and transvenous cardiac biopsy, guided by echocardiography, mediastinoscopy, or thoracotomy, are used to carry out the procedure for a definitive diagnosis.

Take home points

  • Echocardiography continues to be the best first imaging technique for identifying cardiac/pericardial malignancies.
  • Cardiac MRI is the best non-invasive technique; gives supplementary information for tissue characterization, and evaluation of myocardial infiltration.
  • CT is essential to determine the presence of extracardiac metastatic dissemination.
  • The precise combination of imaging modalities should be individualized for each patient. Histopathological analysis of any excised cardiac mass is the diagnostic gold standard. It enables the determination of benign or malignant origin and accurate histotype.[4]

References

  1. Bhattacharyya S, Khattar R, Senior R (2013). "Characterisation of intra-cardiac masses by myocardial contrast echocardiography". Int J Cardiol. 163 (1): e11–3. doi:10.1016/j.ijcard.2012.06.098. PMID 22805540.
  2. Geibel A, Kasper W, Keck A, Hofmann T, Konstantinides S, Just H (1996). "Diagnosis, localization and evaluation of malignancy of heart and mediastinal tumors by conventional and transesophageal echocardiography". Acta Cardiol. 51 (5): 395–408. PMID 8922046.
  3. Hoffmann U, Globits S, Schima W, Loewe C, Puig S, Oberhuber G; et al. (2003). "Usefulness of magnetic resonance imaging of cardiac and paracardiac masses". Am J Cardiol. 92 (7): 890–5. doi:10.1016/s0002-9149(03)00911-1. PMID 14516903.
  4. Bussani R, Castrichini M, Restivo L, Fabris E, Porcari A, Ferro F; et al. (2020). "Cardiac Tumors: Diagnosis, Prognosis, and Treatment". Curr Cardiol Rep. 22 (12): 169. doi:10.1007/s11886-020-01420-z. PMC 7547967 Check |pmc= value (help). PMID 33040219 Check |pmid= value (help).